153 related articles for article (PubMed ID: 26648023)
41. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
Kong X; Luo J; Xu T; Zhou Y; Pan Z; Xie Y; Zhao L; Lu Y; Han X; Li Z; Liu L
Oncol Rep; 2017 Jun; 37(6):3423-3432. PubMed ID: 28498435
[TBL] [Abstract][Full Text] [Related]
42. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
[TBL] [Abstract][Full Text] [Related]
43. CCT327 enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cell survival proteins in TRAIL-resistant human leukemia cells.
Liu YJ; Lin YC; Lee JC; Kuo SC; Ho CT; Huang LJ; Kuo DH; Way TD
Oncol Rep; 2014 Sep; 32(3):1257-64. PubMed ID: 25017974
[TBL] [Abstract][Full Text] [Related]
44. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
45. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Kim JH; Chung YH; Lee SH
Biochem Biophys Res Commun; 2016 Apr; 473(2):586-92. PubMed ID: 27033605
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
[TBL] [Abstract][Full Text] [Related]
47. Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells.
Wang MJ; Liu S; Liu Y; Zheng D
Neurosci Res; 2007 Sep; 59(1):40-6. PubMed ID: 17707539
[TBL] [Abstract][Full Text] [Related]
48. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
[TBL] [Abstract][Full Text] [Related]
49. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
Son YG; Kim EH; Kim JY; Kim SU; Kwon TK; Yoon AR; Yun CO; Choi KS
Cancer Res; 2007 Sep; 67(17):8274-84. PubMed ID: 17804742
[TBL] [Abstract][Full Text] [Related]
50. Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells.
White SJ; Lu P; Keller GM; Voelkel-Johnson C
Cancer Biol Ther; 2006 Dec; 5(12):1618-23. PubMed ID: 17106251
[TBL] [Abstract][Full Text] [Related]
51. Dapagliflozin induces apoptosis by downregulating cFILP
Jang JH; Lee TJ; Sung EG; Song IH; Kim JY
Oncol Lett; 2022 Nov; 24(5):401. PubMed ID: 36276495
[TBL] [Abstract][Full Text] [Related]
52. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
[TBL] [Abstract][Full Text] [Related]
53. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
Lee JT; Lee TJ; Park JW; Kwon TK
Int J Oncol; 2009 May; 34(5):1455-60. PubMed ID: 19360359
[TBL] [Abstract][Full Text] [Related]
54. Cepharanthine Enhances TRAIL-Mediated Apoptosis Through STAMBPL1-Mediated Downregulation of Survivin Expression in Renal Carcinoma Cells.
Shahriyar SA; Woo SM; Seo SU; Min KJ; Kwon TK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360403
[TBL] [Abstract][Full Text] [Related]
55. Jaceosidin induces apoptosis through Bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma Caki cells.
Woo SM; Kwon TK
Chem Biol Interact; 2016 Dec; 260():168-175. PubMed ID: 27729209
[TBL] [Abstract][Full Text] [Related]
56. Targeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivo.
Jiang XL; Zhang Y; Luo CL; Wu XH
Asian Pac J Cancer Prev; 2012; 13(12):6463-8. PubMed ID: 23464475
[TBL] [Abstract][Full Text] [Related]
57. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells.
Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH
Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975
[TBL] [Abstract][Full Text] [Related]
58. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
59. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
Oncogene; 2008 Apr; 27(18):2513-24. PubMed ID: 17982483
[TBL] [Abstract][Full Text] [Related]
60. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP.
Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK
Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
